Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Rheumatology
Clinical Trials: Amyloidosis
A listing of clinical trials currently looking for volunteers to enroll in Amyloidosis studies. Click on the closest city to find more detailed information on a research study in your area.
California
Los Angeles : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Orange : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
San Francisco : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Stanford : Stanford University Cancer Institute
A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis
Stanford : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
View More »
Stanford : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Colorado
Aurora : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Illinois
Chicago : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Oak Lawn : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Indiana
Indianapolis : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Maryland
Baltimore : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Bethesda : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Massachusetts
Boston : Boston Medical Center
Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis
Boston : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Boston : Boston Medical Center
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
Boston : Tufts Medical Center
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
Boston : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Michigan
Detroit : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Detroit : Karmanos Cancer Institute
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
Minnesota
Rochester : Celtic Investigator site-Mayo Clinic
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Rochester : Mayo Clinic
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
New York
New York : Memorial Sloan-Kettering Cancer Center
Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis
New York : Mount Sinai School of Medicine
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
New York : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Ohio
Cleveland : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Columbus : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Columbus : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Oregon
Portland : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Pennsylvania
Philadelphia : Fox Chase Cancer Center
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
Philadelphia : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Pittsburgh : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Argentina
Buenos Aires : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Ciudad de Buenos Aires : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Sante Fe : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Belgium
Leuven : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Leuven : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Brazil
Curitiba, Parana : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Ilha do Fundao : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Sao Paulo : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Bulgaria
Sofia : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Canada
Toronto : University Health Network, Princess Margaret Hospital
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
Chile
Santiago : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Cyprus
Nicosia : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Czech Republic
Praha 2 : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Denmark
Arhus N : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Egypt
Cairo : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Cairo : Celtic investigator site - Hamoud
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Cairo : Celtic investigator site -Gohar
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Finland
Helsinki : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
France
Creteil : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Créteil : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Le Mans : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Lille : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Limoges : CHU Limoges
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
View More »
Paris : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Toulouse Cedex9 : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Germany
Berlin : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Hannover : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Heidelberg : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Heidelberg : University of Heidelberg
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
Heidelberg : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
View More »
Munster : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
India
Jaipur : Celtic Inestigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Kanpur : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Manipal : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Nadiad : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
New Delhi : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Israel
Haifa : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Holon : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Ramat-Gan : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Italy
Bologna : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Messina : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Modena : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Pavia : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Pavia : Amyloidosis Research & Treatment Center
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
View More »
Pavia : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Reggio Emilia : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Japan
Kumamoto : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Matsumoto : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Lithuania
Kaunas : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Vilnius : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Mexico
Aguacalientes : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Ica : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Monterrey : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Tlalpan : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Netherlands
Groningen : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Groningen : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Maastricht : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Peru
Ica : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Lima : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Poland
Olsztyn : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Warszawa : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Wroclaw : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Portugal
Lisbon : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Porto : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Russian Federation
Ekaterinburg : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Kemerovo : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Moscow : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Novosibirsk : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
St. Petersburg : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
View More »
Voronezh : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Spain
Barcelona : Celtic Investigator Site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Barcelona : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Malaga : Celtic Investigator Site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Sweden
Stockholm : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Umea : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Switzerland
Basel : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Taiwan
Taipei : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Taipei City : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Tunisia
Monastir : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Sfax : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Sousse : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Tunis : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Turkey
Adana : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Ankara : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Eskisehir : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Istanbul : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Ukraine
Donetsk : Celtic investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Kyiv : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
United Kingdom
Cambridge : GSK Investigational Site
SAP Depleter Dose Assessment Study in Patients
Leeds : Clinical Site
Trial to Evaluate Safety, Tolerability, and Parmacokinetics of ALN-TTR02 in Healthy Volunteer Subjects
London : Celtic Investigator site
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
London : Clinical Site
Trial to Evaluate Safety, Tolerability, and Parmacokinetics of ALN-TTR02 in Healthy Volunteer Subjects
